St. Jude Riata Problems Most Frequently Seen in Large Diameter Leads

New research suggests that the problems with recalled St. Jude Riata defibrillator leads, which were removed from the market last year amid reports that the small wires may poke through the insulation, appears to occur most often among those with a larger diameter. 

St. Jude Medical released a summary of preliminary findings from its Riata Lead Evaluation Study (PDF) this week, which indicates that there is a 24 percent chance that the insulation on conductors in large diameter St. Jude Riata may fail, allowing the wire to become exposed in the patient’s body. That compares to only a 9.3% rate of the externalized conductor problems being found among small diameter St. Jude leads.

The study involved 724 patients at 20 locations in the U.S. and Canada. The finalized study will involve data from another 51 patients in Japan.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

St. Jude Riata Defibrillator Lead Problems

The St. Jude Riata, Riata ST, QuickSite and QuickFlex defibrillator leads have all been found to contain potential defects that may make the wires prone to penetrating through the insulation.  This may cause patients to suffer dangerous and potentially life-threatening shocks or prevent the defibrillator from delivery a life-saving jolt when it is needed.

The leads are used with internal defibrillators that are implanted near a patient’s heart to monitor the heart rhythms and provide a life-saving electrical shocks if necessary. The leads connect the defibrillator to the heart and deliver the charge, but they are supposed to remain covered by insulation once implanted. However, in some cases it appears that the St. Jude lead wires have poked the insulation, leaving parts of the leads are bare and uncovered inside patients’ bodies.

Reports have suggested that the recalled leads pose a serious health concern for patients, as it is largely impractical for patients to have the small lead wires removed.  This causes patients to require more frequent medical follow up examinations and the only thing they can do is hope that they do not experience any of the problems associated with the small wires that connect their implanted defibrillator to their heart.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S.
Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S. (Posted 2 days ago)

A recently filed Depo-Provera lawsuit questions why Pfizer updated the drug label in Europe, to warn about the risk of meningioma brain tumors, but failed to provide the same Depo-Provera warnings to U.S. consumers and doctors.

Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week
Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week (Posted 4 days ago)

U.S. District Judge presiding over all federal hair relaxer lawsuits will meet with lawyers involved in the litigation on Thursday, to discuss the status of the claims and when to move forward with bellwether cases.